So why do the journalists ignore him to focus on Wolff?
So why do the journalists ignore him to focus on Wolff? Could it be ... they have an agenda to destroy Trump and facts don't make a difference?
Delusional people:
are people who believed President Obama when he said you could keep your doctor and your health plan if you liked it and that Obamacare would lower premiums.
are ones who believed that a video caused the attack in Benghazi.
are those who believe dropping millions in the middle of the night in Iran was not ransom.
are those who believe massive government regulations, higher taxes and borrowing make the economy grow faster despite historical facts.
are people who believe that Cuba will improve while communists are still in charge.
are those who continue to peddle Russian collusion with Trump.
are those who say that James Comey, Eric Holder, Loretta Lynch and others at Justice and FBI operate independently.
are people who believe that Hillary and her aides didn't intend to break the law.
and the most delusional at all are any who say that global warming caused by humans is what causes record cold.
I am sure that others can give many more examples of where the Obama administration was delusional.
I'll take the president who has given us the fastest economic growth in 13 years, given us record-low black unemployment, has given us high consumer confidence, high business confidence, a 12-year high in home builder confidence, reduced regulations rapidly and is giving the power and purse back to the people as fast as he can. Freedom and prosperity are good.
I'll take a leader who leads foreign policy instead of leading from behind. Appeasing North Korea and Iran doesn't work.
Factually, the Trump Administration is doing very good. Factually, Obama gave us the slowest economic recovery in seventy years.
Who is delusional? Trump or journalists and Democrats who are seeking to destroy him every day?
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP
Scroll down for more posts ▼
Top 10 Most Recent News Articles
A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...
Continue Reading
AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...
Continue Reading
History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...
Continue Reading
Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...
Continue Reading
Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....
Continue Reading
You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...
Continue Reading
Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...
Continue Reading
Top 5 Most Recently Viewed Articles
Understanding the Recent Silver Surge The recent spike in silver prices, surpassing $100 per ounce, marks a transformative moment in the commodity market. This extraordinary increase shifts the focus from mere speculation to real value creation driven by tangible resource discoveries. The new dynamics of the silver supply chain, particularly influenced by policy changes...
Continue Reading
Unveiling Grange La Chapelle 2021 Grange La Chapelle 2021 is more than just a wine; it is a remarkable fusion of cultures and traditions. This exquisite blend uniquely brings together the storied heritage of French wine-making and the innovative spirit found in Australian viticulture. The collaboration between celebrated wine legends embodies the essence of curiosity and...
Continue Reading
California Parents Rally Against CBD Ban Affecting Their Children A group of concerned parents in California is reacting strongly to a proposed ban on hemp products containing THC that Governor Gavin Newsom has put forth. This emergency measure poses a significant threat to essential treatments that many children with chronic and rare diseases depend on, especially those...
Continue Reading
Aegis Resources Ltd. Grants Stock Options to Directors and Consultants Aegis Resources Ltd. announces an exciting new development with the grant of 3,625,000 stock options to four directors and selected consultants. This is a strategic move aimed at strengthening its management team while aligning their interests with the company's growth. The options come with an...
Continue Reading
Stock Performance Overview Alphabet Inc (NASDAQ: GOOG) has experienced a noticeable dip in its stock value following OpenAI's recent announcement of ChatGPT Atlas, a new AI-powered web browser. This introduction is perceived as a direct challenge to Google's dominance in the search engine and web browser markets, prompting a wave of market reactions from investors....
Continue Reading